General MedicationsSUBLINGUALGeneric

ZOLPIDEM TARTRATE

Standard Dose

10MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview ZOLPIDEM TARTRATE is listed in Drugs@FDA under application 202657 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ZOLPIDEM TARTRATE Form and strength TABLET;SUBLINGUAL - 10MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2024-12-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOLPIDEM TARTRATE is listed in Drugs@FDA under application 202657 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ZOLPIDEM TARTRATE Form and strength TABLET;SUBLINGUAL - 10MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2024-12-06 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.